The study has been conducted by the Microdose’s collaborators at the University of Pittsburgh with atropine sulfate delivered from the MicroDose proprietary dry powder inhaler (DPI). The Phase
NKTR-181, a mu-opioid analgesic investigational drug candidate, was created using Nektar’s small molecule polymer conjugate technology. The Phase 1 study is assessing the pharmacokinetics, pharmacology, safety and efficacy
The products to be developed by the company are in-licensed and own products and the larger focus is on self-researched products. Elder Pharmaceuticals director Alok Saxena said they
The NDA, submitted on 7 April 2011, includes data from two randomized double blind phase 3 clinical trials that compared 0.5% ivermectin cream with a vehicle control (placebo).
As per the terms of the agreement, Affectis Pharma will license exclusive rights to Merck for the development and commercialization of the proposed compounds. Affectis Pharma is entitled
Developed by GW Pharmaceuticals, Sativex (Delta-9-Tetrahydro-cannabinol (THC) and Cannabidiol (CBD)) is in phase III clinical development for the treatment of cancer pain, as the next indication following MS
The virtual trial, being conducted under an investigational new drug (IND) application using electronic tools, allows patients to participate in the clinical trial regardless of their proximity to
EPI-743, an orally absorbed small molecule that readily crosses into the central nervous system, works by targeting an enzyme NADPH quinone oxidoreductase 1 (NQO1). EPI-743 is in phase
As per the agreement, Neuralstem will allow SPI to market the development and licensing rights to its neurogenic compound NSI-189. NSI-189, indicated as a treatment for major depression
The awarded money will be used by OPKO’s wholly-owned Mexican subsidiary Exakta-OPKO to enhance the development of research projects in ophthalmology, infectious disease and oncology. OPKO chairman and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.